课题基金 / 基金详情

项目摘要

项目成果

Mark F Bear的其他基金

相似基金

相关文献

中文摘要
翻译
弱视是一种常见的视力残疾形式,出现在婴儿期和早期 儿童时期,两只眼睛对视觉皮层的输入不平衡(对于 例如,由于眼睛错位、不对称屈光或混浊, 一只眼睛的障碍)。弱视的特征是一只眼睛的视力非常差, 以及随之而来的立体视觉的丧失。对弱视治疗方法的改进的需求是 广泛承认。 过去50年的动物研究揭示了 弱视有充分的文献证明,暂时性单眼剥夺会改变 初级视觉皮层中使皮层神经元无反应的突触强度 对眼睛的刺激。然而,对这些机制知之甚少, 帮助弱视康复我们最近发现, 局部麻醉的视网膜在大脑中产生运动变化, 完全恢复的影响,早期生活单眼剥夺时,麻醉 会慢慢消失我们的目标是揭示这种复苏如何发生的机制, 并确定这些知识是否可以转化为新的和更好的治疗方法, 弱视
英文摘要
Amblyopia is a prevalent form of visual disability that arises during infancy and early childhood when inputs to the visual cortex from the two eyes are poorly balanced (for example, by misalignment of the eyes, asymmetric refraction, or opacities and obstructions of one eye). Characteristics of amblyopia are very poor acuity in one eye, and an attendant loss of stereopsis. The need for improved treatments for amblyopia is widely acknowledged. Animal studies over the past 50 years have uncovered the pathophysiology of amblyopia. It is well documented that temporary monocular deprivation alters the strength of synapses in primary visual cortex that renders cortical neurons unresponsive to stimulation of the deprived eye. However, much less is known about the mechanisms that serve recovery from amblyopia. We recently discovered that temporarily inactivating the retinas with a local anesthetic sets in motion changes in the brain that enable complete recovery from the effect of early life monocular deprivation when the anesthetic wears off. Our objectives are to uncover the mechanism for how this recovery occurs, and to determine if this knowledge can be translated into new and better treatments for amblyopia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathophysiology and treatment of fragile X and related disorders
Pathophysiology and treatment of fragile X and related disorders
Using the principles of synaptic plasticity to promote recovery from amblyopia
Using the principles of synaptic plasticity to promote recovery from amblyopia
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: